[Surgery after neo-adjuvant therapy of non-small cell lung cancer. Preliminary results].
The Authors report their personal experience of surgical treatment following neo-adjuvant therapy in NSCLC (III a N2) in order to assess: 1) the feasibility and safety of surgical treatment following major responses to neoadjuvant chemotherapy; 2) the sectile rate; and 3) the survival rate. Preliminary results show that: 1) chemotherapy using cisplatin and VP-16 gives a high rate of major responses in these patients; 2) surgery is feasible; 3) there is high radical sectile rate; 4) further research is needed to obtain statistical significance.
Mercati
U
U
Unità di Chirurgia, Ospedale R. Silvestrini, Perugia.
Fiaschini
P
P
Darwish
S
S
Minotti
V
V
Crinò
L
L
Tonato
M
M
Maranzano
E
E
Checcaglini
F
F
Meacci
M
M
Cavaliere
A
A
D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000601:surgery* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D016019:Survival Analysis
Chirurgia dopo terapia neo adiuvante del cancro del polmone non a piccole cellule. Risultati preliminari.